Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: Long-term follow-up of the STI571 0102 and 0109 trials
- Richard T. Silver,
- ,
- Roger Waltzman,
- Manisha Mone,
- Hagop Kantarjian
- Cornell University,
- University of Texas MD Anderson Cancer Center,
- Novartis
Scholary Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 743-744 (2 pages)Journal (Volume, Issue Number)
Haematologica (Volume 94, Issue 5)Publication milestones
- Published - 05/2009
Publication status
Published - 05/2009
ISSN
0390-6078Publication IDs
- Scopus: 66049150292
- PubMed: 19407320
- ORCID: /0000-0002-8636-1071/work/68811402
Publication metrics
Metrics
SciVal
citations
29
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
SciVal
FWCI
4.50
SciVal
Author count
5
SciVal
Paper percentile
81
PlumX, opens in new tab
Mentions
1
Citation count
39
Captures
8